Microglial Senescence and Activation in Healthy Aging and Alzheimer's Disease: Systematic Review and

Antonio Malvaso1, Alberto Gatti1, Giulia Negro2

  • 1IRCCS "C. Mondino" Foundation, National Neurological Institute, Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.

Cells
|December 22, 2023
PubMed

Insights

Microglia, the brain's sentinels, change with aging and Alzheimer's disease (AD). Understanding these microglial shifts is key to brain health and developing new AD therapies.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Immunology

Background:

  • Aging is the primary risk factor for neurodegeneration.
  • Microglia, the central nervous system's immune cells, are crucial sentinels with long lifespans.
  • Understanding microglial roles in brain aging and Alzheimer's disease (AD) is vital.

Approach:

  • A systematic literature search was conducted using PubMed and Scopus.
  • 1947 articles were screened, with 289 assessed for full-text eligibility.
  • Microglial transcriptomic, phenotypic, and neuropathological profiles in healthy aging and AD were analyzed.

Key Points:

  • Human and mouse microglia exhibit significant heterogeneity.
  • Microglial function can be context-dependent, acting protectively or harmfully.
  • Aging-related oxidative stress and mitochondrial dysfunction impair microglia, promoting neurodegeneration.

Conclusions:

  • Microglia are pivotal in managing amyloid-beta, tau pathology, and synaptic damage in AD.
  • Maintaining microglial homeostasis is essential for brain health.
  • Further research is needed to fully elucidate human microglial behavior in aging and AD.